NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its third quarter revenues rose more than 3 percent, driven by strong growth in US sales, its gynecology surgical business, and molecular diagnostics.

For the three months ended June 25, the diagnostics firm reported revenues of $717.4 million, up from $693.9 million a year ago, and beating the average consensus Wall Street estimate of $704.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.